Skip to content
Recall Observatory FDA recall evidence

Drug product

8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02

D-1073-2019

March 15, 2019

Class I

Product summary

Firm
Pfizer Inc.
Event
Event 82362
Status
Terminated
Classification
Class I
Quantity
283,400 vials
Official record key
drug-enforcement:D-1073-2019

Official wording

Reason: Presence of Particulate Matter; glass particulates

Code information: Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019

Distribution pattern: United States and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter